Surgical device for the treatment of rhizoarthrosis

The surgical device addresses the complication of subsidence in rhizoarthrosis treatment by using a bioresorbable, inflatable spacer that expands into a saddle shape within the trapezius-metacarpal joint, reducing subsidence and ensuring anatomical conformity, thereby enhancing treatment efficacy and safety.

WO2024241116A1PCT designated stage expired Publication Date: 2024-11-28UNIV DEGLI STUDI MAGNA GRAECIA DI CATANZARO
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2024/054139
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2024-04-29
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current surgical devices for treating rhizoarthrosis, particularly those involving isolated trapeziectomy, face significant challenges such as subsidence, which is the shortening of the first ray of the hand, a common complication that affects the effectiveness of the treatment.

Method used

A surgical device comprising a bioresorbable, inflatable spacer element that is implanted during an isolated trapeziectomy and filled with a saline solution or hyaluronic acid to expand into a saddle-shaped balloon, conforming to the trapezius bone, thereby reducing the risk of subsidence and providing structural support within the trapezius-metacarpal joint.

Benefits of technology

The device effectively reduces or eliminates subsidence, ensuring the first ray's stability and promoting better functional outcomes by conforming to the anatomical shape and being completely bioresorbable within twelve months, thus offering a safer, more effective, and cost-efficient solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2024054139_28112024_PF_FP_ABST
    Figure IB2024054139_28112024_PF_FP_ABST
Patent Text Reader

Abstract

A surgical device (100) for the treatment of rhizarthrosis, comprising a first element (101), introducer, comprising a hollow body (101a) and a cannula (101b), said cannula (101b) being able be fixed to the body (101a), and a second element (102), spacer, inflatable, bioabsorbable, removably fixed in correspondence with one end (102aa) to a corresponding first end (101bb) of the cannula (101b), said second element (102) being able to be implanted, inside a trapezio-metacarpal joint of a patient during an isolated trapeziectomy and according to a first configuration of minimum volume, by means of the first element (101) manually operated by a medical operator. The first element (101) has a substantially cylindrical shape and is made of polylactic acid and of a polymer of caprolactone. The second element (102) is configured to be filled with a physiological solution or with hyaluronic acid, up to a maximum volume configuration.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] DESCRIPTION

[0002] "Surgical device for the treatment of rhizoarthrosis

[0003] The present invention relates to a surgical device for the treatment of rhizoarthrosis.

[0004] In particular, the present invention relates to a surgical device for the treatment of rhizoarthrosis comprising biocompatible components, aimed at reducing or resolving possible complications following more or less invasive interventions for the treatment of trapezius- metacarpal osteoarthritis, i.e. the joint at the base of an inch of a patient's hand, interposed between the trapezius and metacarpal bones.

[0005] The technical field of reference is that of medical devices, and specifically the sector of devices that can be implanted in anatomical sections of a patient during surgery.

[0006] Trapezius-metacarpal arthrosis, or rhizoarthrosis, represents the second most frequent localization of arthritic pathology at the level of the hand after arthrosis of the distal interphalangeal joint of the second finger, with a radiographic incidence of more than 40% in women over 80 years of age and most frequently affecting the nondominant hand. Despite the high prevalence, the disease is not always clinically significant. However, when it becomes symptomatic, the loss of thumb function leads to a functional limitation to the entire affected limb of more than 50%. Many patients suffering from rhizoarthrosis can be successfully treated by various conservative techniques, such as the administration of NSAIDs, the application of braces or physiokinesitherapy . In cases where conservative treatment is not effective, there are numerous surgical solutions available, and these include metacarpal osteotomy in extension, arthroscopy, flying ligament reconstruction, isolated trapeziectomy, trapeziectomy associated with ligament reconstruction and tendon interposition, prosthetic surgery and arthrodesis.

[0007] There are numerous critical issues, still unresolved as widely demonstrated by numerous scientific literatures, for each of the surgical solutions currently available.

[0008] For example, flying ligament reconstruction is technically difficult, prosthetic surgery is often burdened by very high rates of early implant failure and isolated trapeziectomy, considered the most effective surgical technique in the long term, is associated with the risk of subsidence, the loss of length of the first radius of a hand. Several surgical devices for the treatment of rhi zoarthrosis are currently known from a consultation of the patent literature .

[0009] A first example of a known technical solution is described in US patent application US2016346093A1 , which has as its obj ect an implant for the trapezius-metacarpal j oint comprising a body defining a median plane , a surface of the metacarpal j oint and a surface o f the trapezius j oint . A first central region of the surface of the metacarpal j oint is located on an opposite side of the median plane from a second central region of the surface of the trapezius j oint . The first and second central regions correspond respectively to the profiles of a first axial segment and a second axial segment . The first and second axial segments are selectable between a cylinder, a cone and a torus and are centered on a first axis and a second axis , respectively, where the first and second axes , when proj ected in the median plane , are substantially perpendicular to each other . Also disclosed is a method of positioning the implant in a trapezius-metacarpal j oint comprising the steps of accessing an articular area between a metacarpal and a trapezius of a patient , positioning the implant in the articular area, and orienting the implant in the articular area such that the surface of the metacarpal j oint of the implant is directed toward the metacarpal, and the surface of the trapezius joint of the implant is directed toward the same trapezius.

[0010] Still, the text of U.S. Patent Application US2015005891A1 describes a spacer to be implanted in a patient, comprising a sterilized portion of cartilage tissue from allograft. This portion forms a 'Y' profile with a base adapted to fit within a first carpo-metacarpal or carpo- metatarsal joint of the patient, and has a first area adapted to attach to a trapezius adjacent to the joint, and a second arm adapted to attach to a metacarpal or proximal metatarsal adjacent to the joint. One procedure for implanting the spacer involves exposing a joint and abrading a bone surface within the joint to induce superficial bleeding, with the base of the spacer then being inserted into the joint. The first arm of the spacer is made to adhere to the first bone of the joint, while the second arm of the spacer is made to adhere to the second bone of the joint. The patent text also mentions a kit for the surgical implantation of the spacer.

[0011] Still, US2013 / 331946A1 discloses a surgical device comprising a first smooth surface over which a small bone may slide, and may include an opening extending through the same device to promote fibrotic development through the opening from one direction, either from the thumb metacarpal or the trapezium. WO2010 / 129882A1 mentions a shaped implant to generally imitate the shape of the trapezium or its parts , such as to form a 'C' shaped receptacle or cuf f , to receive the first metacarpal and so that the first and second metacarpal proj ections extend along both sides of the first metacarpal .

[0012] Finally, the text of the Italian patent IT20170056525A1 mentions a trapezius-metacarpal prosthetic implant comprising a substantially lenticular biconvex spacer element adapted to be positioned between the bone of the trapezius and the base of the first metacarpal of the hand, at least one first means of fixation acting, when the implant is arranged in the prosthetic seat , to connect the spacer element with the first metacarpal and keep it in position, without preventing the movements of the first metacarpal itsel f . The first fixing means comprises at least one ligament adapted to cross the first metacarpal substantially longitudinally through a first channel obtained between the base of the first metacarpal and the outer wall of the same first metacarpal . The implant al so includes at least one second fixation means adapted, when the implant is arranged in the prosthetic site , to connect the metaphysis of the first metacarpal with the distal diaphysis of the second metacarpal and to exert an adduction and li fting force on the spacer element when it is inserted in the prosthetic site. Said second fixing means comprises at least one ligament adapted to traverse obliquely the first and the second metacarpal through a second channel, in the first metacarpal, and a third channel, in the second metacarpal, substantially aligned with each other and obtained between the outer wall of the first metacarpal and the ulnar wall of the second metacarpal.

[0013] However, surgical devices for the treatment of rhizoarthrosis such as those described suffer from inherent limitations, for example they do not provide an efficient solution to the problem of the onset of one of the complications that often follow an isolated trapeziectomy, i.e. subsidence, i.e. the shortening of the first ray of the hand of a patient suffering from rhizoarthrosis.

[0014] The object of the present invention is to provide a surgical device for the treatment of rhizoarthrosis that allows to avoid or considerably reduce the risk of subsidence, thus having characteristics such as to exceed the limits that still affect the known solutions.

[0015] According to the present invention, there is provided a surgical device for the treatment of rhizoarthrosis, as defined in claim 1.

[0016] For a better understanding of the present invention, a preferred embodiment is now described, by way of non-limiting example only, with reference to the accompanying drawings , in which :

[0017] - figure 1 shows a schematic perspective view of the components of a surgical device for the treatment of rhi zoarthrosis , according to the invention;

[0018] - figure 2 shows an overall perspective view of the surgical device for the treatment of rhi zoarthrosis , according to the invention .

[0019] With reference to such figures and, in particular, to figure 1 , a surgical device for the treatment of rhi zoarthrosis is shown, according to the invention .

[0020] In particular, the surgical device 100 for the treatment of rhi zoarthrosis comprises :

[0021] - a first element 101 , with the function of introducer, comprising a hollow body 101a, similar to a handpiece , and a cannula 101b attachable to said body 101a at respective ends 10 lab, l O lba ;

[0022] - a second, inflatable , bioresorbable spacer element 102 removably fixed at an end 102aa thereof to a corresponding first end l O lbb of the cannula 101b .

[0023] According to one aspect of the invention, the body 101a or handpiece is substantially cylindrical in shape .

[0024] According to one aspect of the invention, the second element 102 is implantable within a trapezius-metacarpal j oint of a patient , during an isolated trapeziectomy operation and in a first configuration of minimum volume , i . e . with the aforementioned second deflated spacer element 102 .

[0025] According to one aspect of the invention, the second member 102 is implantable within the trapezius-metacarpal j oint by means of the first member 101 manually operated by a medical operator, e . g . an orthopaedic surgeon during isolated trapeziectomy .

[0026] According to one aspect of the invention, the second element 102 is adapted to be filled, once implanted in place in the trapezius-metacarpal j oint of the patient during the isolated trapeziectomy, until reaching a second configuration of maximum volume by means of a syringe 50 removably connected to an end l O laa, opposite the first end l O lbb of the cannula 101b, of the body 101a, as best seen in Figure 1 .

[0027] According to one aspect of the invention, the body 101 comprises a button at the end l O laa, a release lever and a further safety button positioned at a side surface of the same body 101 .

[0028] According to one aspect of the invention, the cannula 101b comprises a tube 104 configured for inflating the second element 102 , until reaching the second configuration o f maximum volume , covered by a protective sheath 105 .

[0029] According to one aspect of the invention, once the configuration of maximum volume has been achieved, implanted in the trapezius-metacarpal j oint of the patient suf fering from rhi zoarthrosis , the second spacer element 102 is sealed by the medical operator who acts by pulling the tube 104 , also subordinated to the inflation of the spacer 102 itsel f , in the direction of a rigid ring .

[0030] According to one aspect of the invention, the body 101a has a substantially cylindrical shape .

[0031] According to one aspect of the invention, the second spacer element 102 is configured to be filled, by means of the syringe 50 and through the f irst element 101 , with a saline solution, or by means of hyaluronic acid .

[0032] According to one aspect of the invention, the second element 102 is filled with a physiological solution or hyaluronic acid having a volume of between 3 milliliters and 5 milliliters , and preferably equal to 4 milliliters .

[0033] According to one aspect of the invention, the second element 102 , once filled, according to the second configuration of maximum volume assumes the shape of a bioresorbable inflated balloon having the profile substantially of a saddle , so as to conform to the profile of a trapezius bone , i . e . the trapezius present at the trapezius-metacarpal j oint of the patient undergoing isolated trapeziectomy .

[0034] Advantageously according to the invention, the application of the second spacer element 102 in the trapezius-metacarpal j oint of the patient suf fering from rhi zoarthrosis greatly reduces or eliminates one of the most frequent complications following an isolated trapeziectomy, namely subsidence , which consists in the shortening of the first radius of the hand of the same patient .

[0035] According to another aspect of the invention, the first element 101 is made of polylactic acid and a polymer of the caprolactone .

[0036] According to one aspect of the invention, the percentage by weight of the composition of the first element 101 in polylactic acid is comprised between 60% and 80% , preferably equal to 70% , while the percentage by weight of said composition of the introducer in a polymer of the caprolactone , is comprised between 20% and 40% , preferably equal to 30% .

[0037] According to one aspect of the invention, the aforementioned second element 102 is adapted to be produced in three di f ferent si zes , so as to conform to the di f ferent anatomical characteristics of a wide range of patients . According to another aspect of the invention, as specified, said second element 102 is bioresorbable, starting from three months from the implantation inside the trapezius-metacarpal joint of the patient, and completely bioresorbable within twelve months from said implantation.

[0038] According to one aspect of the invention, the surgical device 100, as a whole, is also referable to the term "ThumBalloon" .

[0039] Therefore, the surgical device for the treatment of rhizoarthrosis according to the invention allows to avoid or considerably reduce one of the complications that can arise as a result of an isolated trapeziectomy, i.e. subsidence, i.e. the shortening of the first radius of the hand of a patient suffering from rhizoarthrosis.

[0040] A further advantage of the surgical device for the treatment of rhizoarthrosis according to the invention is that it is completely bioresorbable within twelve months of its implantation.

[0041] A further advantage of the surgical device for the treatment of rhizoarthrosis according to the invention is that its use is safe for the patient.

[0042] Furthermore, the surgical device for the treatment of rhizoarthrosis according to the invention allows to conform to the anatomical characteristics of a wide range o f patients .

[0043] Furthermore , the surgical device for the treatment of rhi zoarthrosis according to the invention is easy to use . Finally, the surgical device for the treatment of rhi zoarthrosis according to the invention is economical and involves reduced complexity linked to the prototyping and industrialisation phases .

[0044] Finally, it is clear that modi fications and variants can be made to the surgical device for the treatment of rhi zoarthrosis , described and il lustrated herein, without thereby departing from the protective scope of the present invention, as defined in the appended claims .

Claims

CLAIMS1. Surgical device (100) for the treatment of rhizarthrosis, comprising:- a first element (101) , introducer, comprising a hollow body (101a) and a cannula (101b) , said cannula (101b) being able be fixed to the body (101a) ; a second element (102) , spacer, inflatable, bioabsorbable, removably fixed in correspondence with one end (102aa) to a corresponding first end (lOlbb) of the cannula (101b) , said second element (102) being able to be implanted, inside a trapezio-metacarpal joint of a patient during an isolated trapeziectomy and according to a first configuration of minimum volume, by means of the first element (101) manually operated by a medical operator, Characterized in that said first element (101) has a substantially cylindrical shape and is made of polylactic acid and of a polymer of caprolactone, and in that said second element (102) is configured to be filled with a physiological solution or with hyaluronic acid, up to a maximum volume configuration.

2. Surgical device (100) according to claim 1, characterized in that said second element (102) is configured to be filled, once in place inside the trapezio-metacarpal joint of the patient during the isolated trapeziectomy, soas to reach a second configuration of maximum volume, by means of a syringe (50) removably connected to one end (lOlaa) of the body (101a) , opposite to the first end (lOlbb) of the cannula (101b) .

3. Surgical device (100) according to claim 2, characterized in that said second element (102) , once filled according to the second configuration of maximum volume, has substantially the shape of a saddle so as to conform to the profile of a trapezius bone of the patient, said trapezius bone being placed in correspondence with said trapezio- metacarpal joint.

4. Surgical device (100) according to claim 1, characterized in that the weight percentage of the composition of the first element (101) made of polylactic acid is comprised between 60% and 80%, and the weight percentage of said composition made of a polymer of caprolactone is comprised between 20% and 40%.

5. Surgical device (100) according to claim 1, characterized in that said second element (102) is able to be produced in three different sizes.

6. Surgical device (100) according to claim 1, characterized in that said second element (102) is completely bioabsorbable within twelve months from the implantation inside the trapezio-metacarpal joint of the patient.

7. Surgical device (100) according to claim 1, characterized in that said second element (102) is filled with a physiological solution or hyaluronic acid having a volume comprised between 3 milliliters and 5 milliliters.

Citation Information

Patent Citations

  • Surgical technique using a contoured allograft cartilage as a spacer of the carpo-metacarpal joint of the thumb or tarso-metatarsal joint of the toe

    US20150005891A1

  • Trapeziometacarpal joint implant and associated methods

    US20160346093A1

  • Intra-articulatary surgical prosthesis has plastics cup screwed into place and formed of casing separated from multiple layer lining by fluid gap

    FR2803191A1

  • Interpositional biarticular disk implant

    US20060241778A1

  • Expandable joint implant

    US20130331946A1